LONDON, November 11, 2021 /3BL Media/ - Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, celebrates some of the women scientists across the company who contributed to the COVID-19 vaccine research with the launch of a video featuring their stories.
Using Clarivate information and insights, these scientists built the Clarivate COVID-19 dashboard, developed a Coronavirus Disease Profile and provided epidemiological analysis and disease forecasting through our expert consulting practice.
Shyama Ghosh, a Belgium-based senior science editor at Clarivate passionate about Life Sciences and raising awareness of rare diseases, conducted extensive research on COVID-19. Ann Graul, a senior content editor for Clarivate Disease Briefings in Barcelona, was responsible for keeping the Coronavirus Disease Briefing rigorously up to date. Alex Li, a Clarivate epidemiologist and former surgeon based in the United States, provided epidemiological analysis and disease forecasting through the consulting practice at Clarivate. All three scientists shared their experiences working with customers to contribute to the COVID-19 vaccine development in this new video.
“At Clarivate, we believe that diverse viewpoints, backgrounds and life experiences are central to shaping our shared future. Our vision is to improve the way the world creates, protects and advances innovation for a better future. This past year, Clarivate women scientists had a huge impact on humanity with their contributions to COVID-19 vaccine research. We are tremendously proud of the work they have done and their passion for science and research,” said Julia Mair, Chief Marketing and Communications Officer and Head of Sustainability for Clarivate.
Studies show that a diverse workforce contributes to corporate success and that subject diversity and international collaboration bolster a richer academic landscape, contributing meaningfully to global progress towards life-saving, world changing solutions. More than 50% of the science organization at Clarivate are women, including many of the senior leaders. Honoring the fundamental need for diverse lives, perspectives and experiences in improving our world, Clarivate commits to continuing to uplift and empower all colleagues and communities.
# # #
Clarivate™ is a global leader in providing solutions to accelerate the lifecycle of innovation. Our bold mission is to help customers solve some of the world’s most complex problems by providing actionable information and insights that reduce the time from new ideas to life-changing inventions in the areas of science and intellectual property. We help customers discover, protect and commercialize their inventions using our trusted subscription and technology-based solutions coupled with deep domain expertise. For more information, please visit clarivate.com.
Clarivate media contact
Sofía Nogués, Sr. External Communications Manager
KEYWORDS: women in stem, women in science, COVID-19, NYSE:CLVT, Clarivate